Renaissance Technologies - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 3 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q4 2016$364,000
+40.5%
774,603
+108.4%
0.00%
Q3 2016$259,000
+68.2%
371,705
+380.2%
0.00%
Q2 2016$154,000
-86.6%
77,406
-39.6%
0.00%
-100.0%
Q2 2015$1,149,000
+73.3%
128,069
+22.1%
0.00%
+200.0%
Q1 2015$663,000104,9000.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q1 2017
NameSharesValueWeighting ↓
FNY Managed Accounts LLC 75,000$35,258,0000.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 696,455$327,0000.02%
Klingman & Associates, LLC 10,000$5,0000.00%
BLUESTEIN R H & CO LLC 76,500$36,0000.00%
OPPENHEIMER & CO INC 73,500$34,0000.00%
Renaissance Technologies 774,603$364,0000.00%
Walleye Trading LLC 6$00.00%
Bank of New York Mellon Corp 16,660$8,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11,071$5,0000.00%
SIMPLEX TRADING, LLC 200$00.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders